lorazepam has been researched along with Catatonic Schizophrenia in 30 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The resurgence of catatonia following tapering of lorazepam is a common clinical phenomenon." | 7.85 | Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications. ( Ali, SF; Gowda, GS; Jaisoorya, TS; Math, SB, 2017) |
| "The authors describe four cases of catatonia in which topiramate treatment was used." | 7.73 | Topiramate effect in catatonia: a case series. ( McDaniel, WW; Sahota, AK; Spiegel, DR, 2006) |
| "The resurgence of catatonia following tapering of lorazepam is a common clinical phenomenon." | 3.85 | Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications. ( Ali, SF; Gowda, GS; Jaisoorya, TS; Math, SB, 2017) |
| "Patients with catatonia who had more than one episode of catatonia and were treated with the lorazepam-diazepam protocol were identified." | 3.83 | Relapses and recurrences of catatonia: 30-case analysis and literature review. ( Huang, TL; Hung, YY; Lin, CC; Tsai, MC, 2016) |
| "The authors describe four cases of catatonia in which topiramate treatment was used." | 3.73 | Topiramate effect in catatonia: a case series. ( McDaniel, WW; Sahota, AK; Spiegel, DR, 2006) |
| "He understood catatonia as a disease of its own." | 2.46 | Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. ( Fink, M; Shorter, E; Taylor, MA, 2010) |
| "The authors identified 25 cases of catatonia treated with either agent." | 2.44 | Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. ( Ahuja, N; Carroll, BT; Franco, KN; Goforth, HW; Kraus, MF; McDaniel, WW; Muñoz, C; Pozuelo, L; Spiegel, DR; Thomas, C, 2007) |
| "Studies in major depressive disorder have demonstrated that suprathreshold, nondominant (right) hemisphere, unilateral electrode placement ECT has fewer adverse effects, especially cognitive adverse effects, than bitemporal ECT." | 1.40 | Successful use of right unilateral ECT for catatonia: a case series. ( Conway, C; Cristancho, P; Jewkes, D; Mon, T, 2014) |
| "Risperidone treatment was begun (1mg/d and 1." | 1.39 | [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms]. ( Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F, 2013) |
| " We treated catatonic symptoms with drugs within the upper limit of dosage and electroconvulsive therapy (ECT) to determine the maximal response." | 1.34 | Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. ( Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.67) | 18.7374 |
| 1990's | 8 (26.67) | 18.2507 |
| 2000's | 11 (36.67) | 29.6817 |
| 2010's | 9 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SF | 1 |
| Gowda, GS | 1 |
| Jaisoorya, TS | 1 |
| Math, SB | 2 |
| Cristancho, P | 1 |
| Jewkes, D | 1 |
| Mon, T | 1 |
| Conway, C | 1 |
| Lin, CC | 1 |
| Hung, YY | 2 |
| Tsai, MC | 1 |
| Huang, TL | 4 |
| Cummings, TS | 1 |
| Noordsy, DL | 1 |
| Fink, M | 3 |
| Shorter, E | 1 |
| Taylor, MA | 2 |
| Enterman, JH | 1 |
| van Dijk, D | 1 |
| Devi, S | 1 |
| Behere, RV | 2 |
| Varambally, S | 2 |
| Rao, NP | 2 |
| Venkatasubramanian, G | 2 |
| Gangadhar, BN | 2 |
| Mutalik, NR | 1 |
| Kasal, V | 1 |
| Narayanaswamy, JC | 1 |
| Gopinath, S | 1 |
| Saraf, G | 1 |
| Chandy, A | 1 |
| Menard, ML | 1 |
| Yagoubi, F | 1 |
| Drici, M | 1 |
| Lavrut, T | 1 |
| Askenazy, F | 1 |
| Lai, JY | 1 |
| McDaniel, WW | 2 |
| Spiegel, DR | 2 |
| Sahota, AK | 1 |
| Manjunatha, N | 1 |
| Saddichha, S | 1 |
| Khess, CR | 1 |
| Carroll, BT | 1 |
| Goforth, HW | 1 |
| Thomas, C | 1 |
| Ahuja, N | 2 |
| Kraus, MF | 1 |
| Franco, KN | 1 |
| Pozuelo, L | 1 |
| Muñoz, C | 1 |
| Woo, BK | 1 |
| Hatta, K | 1 |
| Miyakawa, K | 1 |
| Ota, T | 1 |
| Usui, C | 1 |
| Nakamura, H | 1 |
| Arai, H | 1 |
| Grignon, S | 1 |
| Forget, K | 1 |
| Durand, M | 1 |
| Huppert, T | 1 |
| Rosebush, PI | 1 |
| MacQueen, GM | 1 |
| Clarke, JT | 1 |
| Callahan, JW | 1 |
| Strasberg, PM | 1 |
| Mazurek, MF | 1 |
| Jaspert, A | 1 |
| Ebert, D | 1 |
| González-Seijo, JC | 1 |
| Ramos, YM | 1 |
| Lastra, I | 1 |
| Carbonell, C | 1 |
| Northoff, G | 2 |
| Wenke, J | 1 |
| Pflug, B | 1 |
| Lausberg, H | 1 |
| Hellweg, R | 1 |
| Braus, DF | 1 |
| Sartorius, A | 1 |
| Khoram-Sefat, D | 1 |
| Russ, M | 1 |
| Eckert, J | 1 |
| Herrig, M | 1 |
| Leschinger, A | 1 |
| Bogerts, B | 1 |
| Henn, FA | 1 |
| Francis, A | 1 |
| Smith, M | 1 |
| Lebegue, B | 1 |
| Ripley, TL | 1 |
| Millson, RC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Interventional Triple-negative Placebo-controlled Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"[NCT06176456] | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for lorazepam and Catatonic Schizophrenia
| Article | Year |
|---|---|
Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature.
Topics: Anti-Anxiety Agents; Catatonia; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental | 2010 |
Idiopathic recurrent catatonia needs maintenance lorazepam: case report and review.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; India; Long-Term Care; Lorazepam; Schizophr | 2007 |
Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes.
Topics: Catatonia; Clinical Trials as Topic; Electroconvulsive Therapy; Excitatory Amino Acid Antagonists; G | 2007 |
Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.
Topics: Adolescent; Age Factors; Age of Onset; Benzodiazepines; beta-N-Acetylhexosaminidases; Diagnosis, Dif | 1995 |
26 other studies available for lorazepam and Catatonic Schizophrenia
| Article | Year |
|---|---|
Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications.
Topics: Adult; Catatonia; Female; GABA Modulators; Humans; Lorazepam; Male; Psychotic Disorders; Recurrence; | 2017 |
Successful use of right unilateral ECT for catatonia: a case series.
Topics: Adolescent; Adult; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive | 2014 |
Relapses and recurrences of catatonia: 30-case analysis and literature review.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Clozapine; Depressive Disorder | 2016 |
Lorazepam reduces the serum brain-derived neurotrophic factor level in schizophrenia patients with catatonia.
Topics: Adult; Brain-Derived Neurotrophic Factor; GABA Modulators; Humans; Lorazepam; Middle Aged; Schizophr | 2009 |
Treatment of catatonic schizophrenia with lorazepam and aripiprazole.
Topics: Adult; Aripiprazole; Female; Humans; Hypnotics and Sedatives; Lorazepam; Piperazines; Quinolones; Sc | 2009 |
The curious case of a catatonic patient.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Delayed-Acti | 2011 |
Physical deformity as sequela of chronic catatonia and response to electroconvulsive therapy: a case report.
Topics: Adult; Contracture; Electroconvulsive Therapy; Hand; Humans; Hypnotics and Sedatives; Lorazepam; Mal | 2011 |
Monocyte abnormality in catatonia: revisiting the immune theory of catatonia.
Topics: Antipsychotic Agents; Catatonia; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Lorazep | 2011 |
Catatonic schizophrenia with cavum septum pellucidum.
Topics: Adult; Female; Humans; Hypnotics and Sedatives; Lorazepam; Schizophrenia, Catatonic; Septum Pellucid | 2012 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Diffe | 2013 |
Catatonic features noted in patients with post-partum mental illness.
Topics: Adult; Benzodiazepines; Catatonia; Cross-Sectional Studies; Depression, Postpartum; Depressive Disor | 2004 |
Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia.
Topics: Adult; Anti-Anxiety Agents; Coma; Diazepam; Dose-Response Relationship, Drug; Drug Administration Sc | 2005 |
Topiramate effect in catatonia: a case series.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Cataplexy; Catatonia; Dose-Res | 2006 |
Catatonia: subtype or syndrome in DSM?
Topics: Amobarbital; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lorazepam; Me | 2006 |
Basal Ganglia calcification and pulmonary embolism in catatonia.
Topics: Adult; Basal Ganglia; Calcinosis; GABA Modulators; Humans; Lorazepam; Male; Pulmonary Embolism; Schi | 2007 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relation | 2007 |
Increased left prefrontal activation during staring/mutism episodes in a patient with resistant catatonic schizophrenia: a near infrared spectroscopy study.
Topics: Adult; Attention; Awareness; Catalepsy; Clozapine; Combined Modality Therapy; Dominance, Cerebral; D | 2008 |
[Benzodiazepine monotherapy in acute schizophrenia].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Diazepam; Humans; Lorazepam; Male; Schizophrenia; Schizop | 1994 |
Lorazepam in treatment of catatonic schizophrenia.
Topics: Adult; Female; Humans; Lorazepam; Schizophrenia, Catatonic | 1993 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; D | 1996 |
["Catatonic dilemma". Therapy with lorazepam and clozapine].
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Clozapine; Diagnosis, Differential; Drug Therapy, | 1998 |
Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI.
Topics: Acute Disease; Adult; Arousal; Brain Mapping; Dominance, Cerebral; Female; Humans; Injections, Intra | 1999 |
ECT response in catatonia.
Topics: Electroconvulsive Therapy; Functional Laterality; Haloperidol; Humans; Lorazepam; Male; Schizophreni | 1992 |
Lorazepam in the treatment of catatonia.
Topics: Adult; Dextroamphetamine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam | 1991 |
Psychogenic catatonia treated with lorazepam.
Topics: Adult; Catatonia; Female; Humans; Lorazepam; Male; Psychophysiologic Disorders; Schizophrenia, Catat | 1988 |
Lorazepam: therapeutic for catatonic schizophrenia?
Topics: Catatonia; Humans; Lorazepam; Schizophrenia, Catatonic | 1988 |